Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation.

Sandi A Kwee,Brenda Y Hernandez,Linda L Wong,Wei Jia,Sumodh Kalathil,Eric M Wu,Jun-Fang Ji

doi:10.20517/2394-5079.2018.87

Abstract

Aim:Worldwide, hepatocellular cancer (HCC) is the fourth leading cause of cancer death and occurs 3 times more commonly in males than females. Current surveillance practices do not fully address gender differences in HCC.Methods:Clinical characteristics and survival were compared between males and females using a prospectively collected database of HCC patients.Results:In a cohort of 1206 patients, 307 (25%) were female who presented with older age, more non-alcoholic fatty liver disease/steatohepatitis (NAFLD/NASH), family history of HCC, and hypertension. Males (75%) were more likely to use alcohol and cigarettes. Females were more likely to undergo HCC surveillance, have smaller tumor size at diagnosis, and less vascular involvement. Males who met Milan criteria were more likely to undergo liver transplant than women who met the criteria. Median/mean survival was similar between the genders. Multivariate analysis showed that NAFLD/NASH was predictive of mortality for both males and females, age and smoking were predictive of mortality for males, and transplant was predictive of survival for males.Conclusion:Gender differences in HCC appear related to both behavioral risk factors and biologic factors. Older females with HCC have more NAFLD/NASH and may be overlooked by current surveillance guidelines. These gender disparities may lend support to future studies of gender-based HCC screening.

Highlights

Hepatocellular cancer (HCC) is the fourth leading cause of cancer death worldwide and approximately 841,000 new cases are diagnosed annually[1]
Current guidelines on HCC surveillance from leading professional organizations focus on high-risk populations, there is no consensus as to the optimal surveillance in those with non-alcoholic fatty liver disease/ steatohepatitis (NAFLD/NASH)
The purpose of this study is to comprehensively evaluate gender differences in a large cohort of HCC patients to better define populations at risk for evaluation in future surveillance studies

Summary

Introduction

Hepatocellular cancer (HCC) is the fourth leading cause of cancer death worldwide and approximately 841,000 new cases are diagnosed annually[1]. In the US, HCC is one of the few cancers that is increasing in both incidence and death[2]. Current guidelines on HCC surveillance from leading professional organizations focus on high-risk populations, there is no consensus as to the optimal surveillance in those with non-alcoholic fatty liver disease/ steatohepatitis (NAFLD/NASH). A large part of the problem is difficulty in identification of the population at risk as many of these patients have undiagnosed NAFLD/NASH. They are typically followed by only primary care physicians for diabetes or hyperlipidemia or perhaps followed by a hematologist for unexplained thrombocytopenia

Objectives

Methods

Results

Discussion

Conclusion